<DOC>
	<DOCNO>NCT02517424</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy vaporize cannabis participant chronic , treatment-resistant posttraumatic stress disorder .</brief_summary>
	<brief_title>Evaluating Safety Efficacy Cannabis Participants With Chronic Posttraumatic Stress Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<criteria>1 . Meet DSM5 criterion chronic PTSD least six month duration . 2 . Have PTSD moderate severity measure score &gt; = 40 PCL5 time baseline assessment . 3 . Have treatment resistant PTSD define meet DSM5 diagnostic criterion PTSD failing , unable tolerate , Health Canadaapproved medication empirically support psychotherapy PTSD adequate dose duration , determine casebycase basis site investigator . 4 . Are least 18 year old . 5 . Are willing commit medication dose delivery method , complete evaluation instrument , attend study visit . 6 . Agree use cannabis provide study staff end Stage 2 agree require cessation period duration study . 7 . Report current hazardous cannabis use , define score &lt; 8 CUDITR time screen . 8 . Abstain cannabis 2week baseline assessment period biochemically verify via urine cannabinoid concentration . 9 . Agree keep study cannabis store secure location share/distribute cannabis individual . 10 . Be stable medication and/or psychotherapy PTSD least one month prior study entry . 11 . Agree report change medication psychotherapy treatment regimen study study staff . 12 . If female childbearing potential , agree use effective form birth control study participation . 13 . Participants must proficient read English , must able effectively communicate investigator site personnel . 14 . Agree participate interventional clinical trial study participation . 15 . Agree donate blood start study treatment 24 hour last dose . 16 . Agree allow collection his/her gender , race , occupation ensure study recruit target population . 1 . Are pregnant nursing , child bear potential practicing effective mean birth control . 2 . Have history primary psychotic disorder , bipolar affective disorder , bipolar disorder psychotic feature , depressive disorder psychotic feature , borderline personality disorder , antisocial personality disorder , positive family history ( first degree relative ) psychotic disorder bipolar affective disorder . 3 . Have allergy cannabis contraindication use cannabis . 4 . Are currently take drug know substrate CYP 3A4 CYP 2C19 , amitriptyline , fentanyl , sufentanil , alfentanil . 5 . Have diagnosis obstructive sleep apnea score &gt; 3 STOPBang questionnaire . 6 . Would present serious suicide risk assess investigator , likely require psychiatric hospitalization course study . 7 . Are able give adequate inform consent . 8 . Are able attend facetoface visit plan move area active treatment period . 9 . Have positive urine drug screen opiate ( unless prescribe contain overthecounter Health Canada approve medication ) , methamphetamine , cocaine amphetamine meet DSM5 criterion substance use disorder ( caffeine nicotine ) Stage 1 2 study . 10 . Have sign ischemia ( define ST elevation depression ) significant arrhythmia ( define atrial fibrillation flutter , ventricular fibrillation flutter ) screen electrocardiogram . 11 . Have abnormal hepatic renal function ( abnormal liver function test elevate creatinine result screen laboratory report ) . 12 . Meet criteria current severe depression ( BDIII score â‰¥30 ) . 13 . During 2week screening period , diagnose dissociative identity disorder eat disorder active purging , evidence significant , uncontrolled hematological , endocrine , cerebrovascular , cardiovascular , coronary , pulmonary , gastrointestinal , neurological disease ; 14 . During 2week screening period , meet criterion cannabis use disorder ( 4 11 DSM5 criterion ) continue cannabis use confirm urine testing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>